Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
Titel:
Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
Auteur:
Kaynar, L. Coppo, P. Scully, M. Rubia, J. De La Peyvandi, F. Cataland, S. Hovinga, J. A. Kremer Knoebl, P. Pavenski, K. Edou, J. Minkue Mi Callewaert, F. Sousa, R. De Passos